The NIHR Leeds Musculoskeletal Biomedical Research Unit (BRU) was originally established in 2008 as part of the NIHR infrastructure to support translational research in priority areas of high disease burden and clinical need. Through this funding, £13 million was awarded from 2009-2016 based on the strong collaborative links and the foundations of excellence in musculoskeletal research activities in Leeds Teaching Hospitals NHS Trust (LTHT) and the University of Leeds, with musculoskeletal diseases a priority research area for both organisations.
In 2016, a further £7 million has been awarded to continue the work within an NIHR Biomedical Research Centre (BRC) from 2017-2022.
Leeds BRC is an international leader in translational musculoskeletal research hosted within LTHT, and bringing together two leading University of Leeds institutes, the Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM) and the Institute of Medical and Biological Engineering (iMBE), both of which have the delivery of patient-focused research driven by scientific evidence as the core of their activities. University of Leeds and LTHT are now the most highly cited English Higher Education Institute and NHS organisation respectively in the area of musculoskeletal disease